Impact of fluvoxamine on outpatient treatment of COVID-19 in Honduras in a prospective observational real-world study.

Autor: Pineda E; Department of Internal Medicine Hospital CEMESA, San Pedro Sula, Honduras., Singh J; Department of Cardiovascular Medicine, University of California, Riverside, Riverside, CA, United States., Pineda MV; Department of Internal Medicine Hospital Mario Catarino Rivas, San Pedro Sula, Honduras., Umanzor JG; Department of Obstetrics and Gynecology Hospital Mario Catarino Rivas, San Pedro Sula, Honduras., Baires F; Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras., Benitez LG; Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras., Burgos C; Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras., Sekhon AK; Sleep Medicine, Kaiser Permanente, Fontana, CA, United States., Crisp N; Wound Care Department El Campo Memorial Hospital, El Campo, TX, United States., Lewis AS; Pharmacy Department El Campo Memorial Hospital, El Campo, TX, United States., Radwanski J; Pharmacy Department Citizens Hospital, Victoria, TX, United States., Bermudez M; Department of Medicine SBH Health System, Bronx, NY, United States., Barjun KS; Department of Internal Medicine Hospital Mario Catarino Rivas, San Pedro Sula, Honduras., Diaz O; Department of Critical Care Hospital Regional del Norte Instituto Hondureño de Seguridad Social, San Pedro Sula, Honduras., Palou E; Internal Medicine Department, Facultad de Ciencas Médicas, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras., Escalante RE; Department of Medicine, Facultad de Ciencas Médicas, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras., Hernandez CI; HEME Clinic, Choluteca, Honduras., Stevens ML; Research Department, Texas A&M College of Medicine, Detar Family Medicine Residency Program, Victoria, TX, United States., Eberhard D; Research Department, Texas A&M College of Medicine, Detar Family Medicine Residency Program, Victoria, TX, United States., Sierra M; Universidad Tecnológica Centroamericana, Tegucigalpa, Honduras., Alvarado T; Infectiology Department, Facultad de Ciencias Médicas, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras., Videa O; Clínica de Atención Medica Integral CAMI, Tegucigalpa, Honduras., Sierra-Hoffman M; Research and Infectious Disease Department, Texas A&M College of Medicine, Detar Family Medicine Residency Program, Victoria, TX, United States., Valerio-Pascua F; Department of Critical Care Hospital CEMESA, San Pedro Sula, Honduras.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2022 Nov 30; Vol. 13, pp. 1054644. Date of Electronic Publication: 2022 Nov 30 (Print Publication: 2022).